Coherus Oncology (CHRS) Share-based Compensation (2014 - 2026)
Coherus Oncology (CHRS) recorded Share-based Compensation of $2.58 million in Q2 2026, down 52.4% from $5.42 million a year earlier but up 8.3% from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Share-based Compensation (2014 - 2026) Analysis & Trends
On a TTM basis, Coherus Oncology's Share-based Compensation came in at $11.14 million as of Jun 30, 2026, down 53.7% year-over-year; for FY2025, it came in at $16.97 million, down 39.0% from FY2024.
- Annual Share-based Compensation has declined for four straight years, with a five-year compound annual growth rate of -15.0% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $27.8 million in FY2024 (-35.5%), $43.11 million in FY2023 (-15.0%), $50.74 million in FY2022 (-1.2%) and $51.36 million in FY2021 (+34.6%).
- Quarterly Share-based Compensation has ranged from $2.39 million in Q1 2026 to $13.85 million in Q2 2022 over the past five years.
- On a year-over-year basis, Share-based Compensation has declined for 14 consecutive quarters, with an average decline of 42.3% over the last eight quarters.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 28.3% in Q3 2021, against a decline of 56.4% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.39 million (Q1 2026), $2.78 million (Q4 2025) and $3.39 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | - |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn | 2.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.58 Mn |
| Mar 31, 2026 | 2.39 Mn |
| Dec 31, 2025 | 2.78 Mn |
| Sep 30, 2025 | 3.39 Mn |
| Jun 30, 2025 | 5.42 Mn |
| Mar 31, 2025 | 5.37 Mn |
| Dec 31, 2024 | 6.38 Mn |
| Sep 30, 2024 | 6.87 Mn |
| Jun 30, 2024 | 7.23 Mn |
| Mar 31, 2024 | 7.32 Mn |
| Dec 31, 2023 | 10.80 Mn |
| Sep 30, 2023 | 9.95 Mn |
| Jun 30, 2023 | 10.08 Mn |
| Mar 31, 2023 | 12.28 Mn |
| Dec 31, 2022 | 11.73 Mn |
| Sep 30, 2022 | 12.28 Mn |
| Jun 30, 2022 | 13.85 Mn |
| Mar 31, 2022 | 12.88 Mn |
| Dec 31, 2021 | 10.95 Mn |
| Sep 30, 2021 | 11.94 Mn |
API Access
Coherus Oncology Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();